Baxter 0.9% Sodium Chloride Injection, USP, 500 mL VIAFLEX Plastic
OFFICIAL-SOURCE RECALL · UNITED STATES
Vitruvias Therapeutics Thyroid Tablets, USP 30 mg Recall: Potential for the Product to be Superpotent
Use the identifiers printed on your item to determine whether this recall may affect the product you own.
CountryUnited StatesPublishedAugust 24, 2026Last updatedAugust 24, 2026Official source last checkedAugust 25, 2026 at 6:11 PM UTC
CHECK THE ITEM YOU OWN
Is your product affected?
- Product
- Thyroid Tablets, USP 30 mg
- Manufacturer
- Vitruvias Therapeutics, Inc
- NDC
- 69680-166-00
- Lot number
- 504950
- Expiration date
- 9/30/2026
The barcode may identify the product type, while the recall may apply only to certain lots, dates or variants. Check all identifiers listed in the official recall.
Why this product was recalled
Potential for the Product to be Superpotent
Hazard
Potential for the Product to be Superpotent
What consumers should do
Consumers with questions about the recall can contact Vitruvias Therapeutics, Inc. by email at safety@vitruvias.com or by phone at (256) 239-9373 Monday through Friday from 9 a.m. to 5 p.m. CT. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Official recall notice
Vitruvias Therapeutics, Inc Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency
Agency: U.S. Food & Drug Administration
Official publication date: August 24, 2026
Read the official FDA recall notice →Scan products you own
Scan products you own once and let RecallGuard monitor future official recalls.
Scan & Monitor Products